(Q41364582)

29 September 2017

1 reference

title

Headache induced by serotonergic agonists--a key to the interpretation of migraine pathogenesis? (English)

1 reference

29 September 2017

1 reference

1 reference

A Panconesi

1

1 reference

29 September 2017

R Sicuteri

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

29 September 2017

1 reference

29 September 2017

volume

17

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

3-14

1 reference

On serotonin and migraine: a clinical and pharmacological review

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Serotonin (5-HT) and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

5-HT1C receptor activation: a key step in the initiation of migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

5-HT2 receptor subtypes: a family re-united?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Hypothesis: serotonin-1C receptor activation in migraine: an alternative point of view with therapeutic implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Serotonin-releasing effects of substituted piperazines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

The effects of 5-HT and m-chlorophenylpiperazine (m-CPP) on the efflux of [3H]-5-HT from human perfused platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Neuroendocrine probes of serotonergic function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders. Correlation with increased serotonergic responsivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effects of fluoxetine ord-fenfluramine on serotonin release from, and levels in, rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Double-blind trial of fluoxetine: chronic daily headache and migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Fluoxetine prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Paroxetine in the treatment of chronic daily headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Acute fluoxetine overdose: a report of 234 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effects of fluoxetine on basal and K(+)-induced tritium release from synaptosomes preloaded with [3H]serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

5-HT and antidepressants: new views from microdialysis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Neurobiological mechanisms involved in antidepressant therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

The effects of oral sumatriptan, a 5‐HT1 receptor agonist, on circulating ACTH and cortisol concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Wolff Award presentation 1993. Anti-migraine drug interactions with cloned human 5-hydroxytryptamine1 receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

An endothelial 5-HT receptor that mediates relaxation in guinea-pig isolated jugular vein resembles the 5-HT1D subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effects of two beta 3-adrenoceptor agonists, SR 58611A and BRL 37344, and of salbutamol on cholinergic and NANC neural contraction in guinea-pig main bronchi in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Pharmacological characteristics of 5-hydroxytryptamine autoreceptors in rat brain slices incorporating the dorsal raphe or the suprachiasmatic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Recurrent depression after sumatriptan administration for treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Clinical Neurophysiology and Neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

5HT2 receptors in cerebral cortex of migraineurs studied using PET and 18F-fluorosetoperone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

m-Chlorophenylpiperazine as a probe of serotonin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effects of age and gender on CNS serotonergic responsivity in normal adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effect of oestrogen and progesterone on noradrenergic nerves and on nerves showing serotonin-like immunoreactivity in the basilar artery of the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Estrogen withdrawal selectively increases serotonin reactivity in rabbit basilar artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

"Menstrual" migraine: towards a definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Side effects of ergotamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

The Nitric Oxide Hypothesis of Migraine and Other Vascular Headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effect of acute administration of L-tryptophan on the release of 5-HT in rat hippocampus in relation to serotoninergic neuronal activity: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Serotonin syndrome complicating migraine pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

The safety of concomitant use of sumatriptan and antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Relation between yawning behavior and central serotonergic neuronal system in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

Serotonin receptors: subtypes, functional responses and therapeutic relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1701003.X

10.1046/J.1468-2982.1997.1701003.X

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference